文献速递头颈外科

人乳头瘤病毒相关恶性肿瘤时代早期扁桃体癌的治疗

Treatment of Early Stage Tonsil Cancer in the Age of Human Papillomavirus-Associated Malignancies.
PubMed 文献 · Otolaryngol Head Neck Surg · 2020-12-08

基于美国国家癌症数据库2010-2017年4720例T1-2N0M0扁桃体鳞癌的回顾性队列研究显示,HPV阳性患者3年生存率高于HPV阴性患者(93.2% vs 77.8%,P < .001);HPV阳性患者中不同治疗方式生存无显著差异,而HPV阴性患者中手术为基础的治疗生存优于非手术治疗。

要点

  • HPV阳性早期扁桃体癌手术或放疗生存相似。
  • HPV阴性患者手术为基础治疗生存优于非手术。
  • HPV状态影响早期扁桃体癌治疗选择与预后。

核心结论

  • 早期HPV阳性扁桃体癌手术或放疗生存相似,HPV阴性者手术为基础治疗生存更长。

研究设计与样本

  • 历史性队列研究,回顾美国国家癌症数据库2010-2017年4720例T1-2N0M0扁桃体鳞癌患者。

主要发现

  • 2759例(58.5%)接受HPV检测,其中1758例(63.7%)HPV阳性,1001例(36.3%)HPV阴性。
  • HPV阳性患者3年生存率93.2%,高于HPV阴性患者的77.8%(P < .001)。
  • HPV阳性患者中不同治疗队列生存无显著差异。
  • HPV阴性患者中,手术为基础的治疗3年生存率84.6%,高于非手术治疗的69.3%(P < .001)。
  • HPV阴性患者中,扁桃体切除+颈清扫+放疗3年生存率86.0%,高于化放疗的69.6%(P = .01)。

关键数值与推荐

  • HPV阴性患者倾向评分匹配后手术组3年生存率84.9%,非手术组67.1%(P < .001)。

临床怎么用

  • 早期HPV阳性扁桃体癌可考虑手术或放疗,HPV阴性者应优先考虑手术为基础的治疗。

局限性

  • 回顾性研究设计,结果需随机前瞻性试验进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the patterns of care and outcomes of treatment of early stage tonsil cancers, controlling for human papillomavirus (HPV) status. STUDY DESIGN: Historical cohort study. SETTING: National Cancer Database (NCDB). METHODS: Review of the NCDB between 2010 and 2017 for all T1-2N0M0 tonsillar squamous cell carcinoma (SCC). Demographics, clinical characteristics, HPV status, treatment regimens, and survival were analyzed. RESULTS: A total of 4720 patients were identified with early stage SCC of the tonsil. Most were tested for HPV (2759 [58.5%]). Among tested patients, 1758 (63.7%) were positive for HPV and 1001 (36.3%) were negative for HPV. HPV-positive patients had higher 3-year survival compared to HPV-negative patients (93.2% vs 77.8%, P < .001). Among HPV-positive patients, there was no significant difference in survival between treatment cohorts. However, in the HPV-negative cohort, 3-year survival was higher in both bimodality surgical-based settings (tonsillectomy + neck dissection + radiotherapy, 86.0% vs chemoradiotherapy, 69.6%, P = .01) and for all surgical-based treatments when compared to nonsurgical management (84.6% vs 69.3%, P < .001). This difference was maintained in multivariable regression controlling for age, sex, comorbidities, clinical T stage, and treatments. In a subpopulation of HPV-negative patients propensity score matched by all factors significant in multivariable analysis, 3-year survival remained higher in the surgically treated group compared to the nonsurgically treated cohort (84.9% vs 67.1%, P < .001). CONCLUSIONS: Surgical- or radiation-based treatment resulted in similar survival in early stage HPV-positive tonsil cancer. Surgical-based treatments were associated with longer survival in HPV-negative cancers. These findings should be further investigated in a randomized prospective trial.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Patel EJ, Zhu AW, Oliver JR, et al. Treatment of Early Stage Tonsil Cancer in the Age of Human Papillomavirus-Associated Malignancies. Otolaryngol Head Neck Surg. 2020. PMID: 33290171. doi:10.1177/0194599820973256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。